Site Search

... and provider groups in years to unite on a new health policy, we are glad to see that the Nebraska legislature recognizes the importance of biomarker testing and access to precision medicine for patients living with chronic disease.  We have concerns about the final bill language and will ... to ensure equitable access for all Nebraskans who can benefit.  The final bill language, which was signed by Gov. Pillen this week, limits biomarker testing coverage to an incomplete list of diseases and conditions. For example, current, proven applications in rare disease ...